Aurobindo pharma looks to continue its uptrend
1. Cup and handle breakout and retest
2. Price surge from long-term trendline
3. 20-50 EMA support
4. Rising EPS and Sales
2. Price surge from long-term trendline
3. 20-50 EMA support
4. Rising EPS and Sales
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。